bisoprolol has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, KH | 1 |
| Dearden, C | 1 |
| Gruber, P | 1 |
1 other study available for bisoprolol and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Rituximab-induced Takotsubo syndrome: more cardiotoxic than it appears?
Topics: Aged; Antihypertensive Agents; Antineoplastic Agents; Bisoprolol; Electrocardiography; Humans; Leuke | 2015 |